NCT06258668
- Conditions
- Moderate-to-severe Plaque Psoriasis
- Locations
-
- Local Institution - 0001 Seoul, South Korea
- Novotech Laboratory Korea Co., Ltd. Seoul, South Korea
Clinical trial condition
Moderate-to-severe Plaque Psoriasis
Explore clinical trials studying Moderate-to-severe Plaque Psoriasis. Study availability and eligibility vary by location and protocol.
7 public trials
1 recruiting study
Moderate-to-severe Plaque Psoriasis trial results
Not Yet Recruiting
Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients
NCT07485764
- Conditions
- Body Weight, Moderate-to-severe Plaque Psoriasis, Nutrition Disorders, +12 more
- Locations
-
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Not Yet Recruiting
A Study of HS-20137 in Participants with Moderate-to-severe Plaque Psoriasis
NCT06844799
- Conditions
- Moderate-to-severe Plaque Psoriasis
- Locations
-
Not specified
NCT04612699
- Conditions
- Moderate-to-severe Plaque Psoriasis
- Locations
-
- The First Affiliated Hospital of China Medical University Shenyang, Liaoning, China
NCT06182384
- Conditions
- Moderate-to-severe Plaque Psoriasis
- Locations
-
- The Second Hospital of Anhui Medical University Hefei, Anhui, China
NCT05787236
- Conditions
- Moderate-to-severe Plaque Psoriasis
- Locations
-
- Mangga Besar Clinic Jakarta, Indonesia
Active, Not Recruiting
Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis
NCT06142357
- Conditions
- Moderate-to-severe Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
- Locations
-
- Novartis Investigative Site Chelyabinsk, Russia
- Novartis Investigative Site Grozny, Russia
- Novartis Investigative Site Izhevsk, Russia
- Novartis Investigative Site Kazan', Russia